Request Discount

Optical Disorders Drugs Market (Prescription Type - Over-the-counter Drugs; Indication - Age-related Macular Degeneration, Glaucoma, Keratitis, and Others; Distribution Channel - Hospital Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

  • Published : February, 2022

  • Rep Id : HC08741

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the optical disorders drugs market provides in-depth analysis of segments and sub-segments in the global as well as regional optical disorders drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional optical disorders drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global optical disorders drugs market. According to the report, the global optical disorders drugs market is projected to grow at a CAGR of 6% around the forecast period of 2021-2027, growing from around USD 38 billion in 2021 to nearly USD 54 billion in 2027.


Market Insight

The eye is a complex sensory organ responsible for vision. Injury or diseases caused to the ocular system can result in vision loss. Different varieties of ophthalmic preparations are available for both therapeutic and diagnostic use.  Medications play a vital role in the management of chronic dry-eye, diabetic retinopathy, glaucoma, infection, inflammation, and macular degeneration. The different classes of drugs used to treat eye disorders are Acetazolamide for glaucoma (Diamox, Eytazox), Acetylcysteine for dry eyes (Ilube), Aciclovir eye ointment., Antazoline and xylometazoline eye drops (Otrivine-Antistin), Apraclonidine eye drops (Iopidine), Atropine eye drops (Minims Atropine), Azelastine eye drop for allergies (Optilast). The most common drugs that are been used to treat bacterial infections of the eye are Ciprofloxacin and norfloxacin.

 

The increasing number of age-related macular degeneration is expected to drive market growth.  AMD is an eye disorder associated with aging and damages sharp and central vision. It is in two different forms wet and dry. AMD is one of the leading causes of permanent impairment of reading and fine or close-up vision among people aging more than 65 years and older due to which the demand for optical disorder drugs is expected to drive in the upcoming years. Moreover, owing to the side effects of the optical disorders oral drugs are expected to hamper the market growth in the upcoming years, as these drugs can harm all parts of the body including the eyes also. The increasing number of patients provides opportunities for the major market player to grow its market

 

Among the regions, North America accounted for the largest share in the global Optical Disorders Drugs Market. The impact of the increasing number of eye diseases, technological advancements in the field of ophthalmology, and the rising aged population. The number of cases of eye diseases is also rising, such as glaucoma, cataract, macular degeneration, and diabetic retinopathy in North American countries which will boost its market in this region in upcoming years. However, the Asia Pacific region is anticipated to grow at the highest rate in the global Optical Disorders Drugs market over the forecast period. The ophthalmology drugs and devices market is driven by governments programs to improve access to comprehensive eye care services and government investments to promote eye care research. Moreover, the introduction of cost-effective drugs to witness more innovative therapies be approved to drive its market growth in this region.

 

Optical Disorders Drugs Market


Segment Covered

The report on the global optical disorders drugs market covers segments such as prescription type, indication, and distribution channel. On the basis of prescription type, the sub-markets include over-the-counter drugs. On the basis of indication, the sub-markets include age-related macular degeneration, glaucoma, keratitis, and others. On the basis of distribution channel, the sub-markets include hospital pharmacies.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Pfizer, Inc., GlaxoSmithKline, Merck & Co., Novartis AG, Roche Holding AG, Santen Pharmaceutical Co., Ltd, and Senju Pharmaceutical Co., Ltd.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the optical disorders drugs market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount